Thiola tiopronin
Ended Awarded
- Contract number
- 36C26123N0829
- Awardee
-
Travere Therapeutics, Inc. UEI JUBZMHK84S36
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $19,987
Award facts
- Contract value 100% obligated
- $19,987.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92130, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order to Travere Therapeutics, Inc., a biopharmaceutical company, for the supply of Thiola (tiopronin), a drug used to treat cystinuria. The $19,987.10 award is part of Travere's Federal Supply Schedule (FSS) contract with the VA under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, valued at up to $14,970,593.10. The delivery order has an ultimate completion date of September 30, 2023. Travere Therapeutics also holds two $25 million Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center for the procurement of Thiola and Cholbam, another one of the company's rare disease medications. These IDVs demonstrate Travere's role as a key supplier of specialized pharmaceuticals to the federal healthcare system, particularly the VA, which provides medical services to over 9 million enrolled veterans.
Quick answers
Who was awarded contract 36C26123N0829?
36C26123N0829 was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on August 25, 2023.
How much is contract 36C26123N0829 worth?
The government has obligated $19,987 on 36C26123N0829.
Is contract 36C26123N0829 an order under another contract?
Yes. 36C26123N0829 is a delivery order under 36F79721D0239, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26123N0829 competed?
The extent of competition for 36C26123N0829 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award